• 9229 Citations
  • 50 h-Index
1993 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 7 Similar Profiles
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Head and Neck Neoplasms Medicine & Life Sciences
Chemoprevention Medicine & Life Sciences
Biomarkers Medicine & Life Sciences
Mouth Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1993 2019

Local Consolidation Therapy (LCT) After First Line Tyrosine Kinase Inhibitor (TKI) for Patients With EGFR Mutant Metastatic Non–small-cell Lung Cancer (NSCLC)

Elamin, Y. Y., Gomez, D., Antonoff, M. B., Robichaux, J. P., Tran, H. T., Shorter, M. K., Bohac, J. M., Negrao, M. V., Le, X., Rinsurogkawong, W., Lewis, J., Lacerda, L., Roarty, E. B., Swisher, S. G., Roth, J. A., Zhang, J., Papadimitrakopoulou, V. A. & Heymach, J. V., Jan 1 2019, In : Clinical Lung Cancer. 20, 1, p. 43-47 5 p.

Research output: Contribution to journalArticle

Epidermal Growth Factor Receptor
Non-Small Cell Lung Carcinoma
Protein-Tyrosine Kinases
Therapeutics
Disease-Free Survival

Targeted Tissue and Cell-Free Tumor DNA Sequencing of Advanced Lung Squamous-Cell Carcinoma Reveals Clinically Significant Prevalence of Actionable Alterations

Lam, V. K., Tran, H. T., Banks, K. C., Lanman, R. B., Rinsurongkawong, W., Peled, N., Lewis, J., Lee, J-K. J., Roth, J., Roarty, E. B., Swisher, S. G., Talasaz, A. A., Futreal, A., Papadimitrakopoulou, V. A., Heymach, J. V. & Zhang, J., Jan 1 2019, In : Clinical Lung Cancer. 20, 1, p. 30-36.e3

Research output: Contribution to journalArticle

DNA Sequence Analysis
Squamous Cell Carcinoma
Lung
Neoplasms
Histology

Validation of the 12-gene predictive signature for adjuvant chemotherapy response in lung cancer

Xie, Y., Lu, W., Wang, S., Tang, X., Tang, H., Zhou, Y., Moran, C., Behrens, M. D. C., Roth, J. A., Zhou, Q., Johnson, D. H., Swisher, S. G., Heymach, J. V., Papadimitrakopoulou, V. A., Xiao, G., Minna, J. D. & Wistuba, I. I., Jan 1 2019, In : Clinical Cancer Research. 25, 1, p. 150-157 8 p.

Research output: Contribution to journalArticle

Adjuvant Chemotherapy
Lung Neoplasms
Genes
Non-Small Cell Lung Carcinoma
Paraffin
3 Citations

24-Month Overall Survival from KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin with or without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous Non–Small Cell Lung Cancer

Borghaei, H., Langer, C. J., Gadgeel, S., Papadimitrakopoulou, V. A., Patnaik, A., Powell, S. F., Gentzler, R. D., Martins, R. G., Stevenson, J. P., Jalal, S. I., Panwalkar, A., Chih-Hsin Yang, J., Gubens, M., Sequist, L. V., Awad, M. M., Fiore, J., Saraf, S., Keller, S. M. & Gandhi, L., Jan 1 2018, (Accepted/In press) In : Journal of Thoracic Oncology.

Research output: Contribution to journalArticle

Pemetrexed
Carboplatin
Non-Small Cell Lung Carcinoma
Survival
Therapeutics
7 Citations

CD38-mediated immunosuppression as a mechanism of tumor cell escape from PD-1/PD-l1 blockade

Chen, L., Diao, L., Yang, Y., Yi, X., Rodriguez, B. L., Li, Y., Villalobos, P. A., Cascone, T., Liu, X., Tan, L., Lorenzi, P. L., Huang, A., Zhao, Q., Peng, D., Fradette, J. J., Peng, D. H., Ungewiss, C., Roybal, J., Tong, P., Oba, J. & 19 othersSkoulidis, F., Peng, W., Carter, B., Gay, C. M., Fan, Y., Class, C. A., Zhu, J., Rodriguez-Canales, J., Kawakami, M., Byers, L. A., Woodman, S. E., Papadimitrakopoulou, V. A., Dmitrovsky, E., Wang, J., Ullrich, S. E., Wistuba, I. I., Heymach, J. V., Qin, F. X. F. & Gibbons, D. L., Sep 1 2018, In : Cancer discovery. 8, 9, p. 1156-1175 20 p.

Research output: Contribution to journalArticle

Tumor Escape
Immunosuppression
Purinergic P1 Receptors
Neoplasms
T-Lymphocytes